SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Worst Managements of Publicly Traded Companies -- Ignore unavailable to you. Want to Upgrade?


To: Ben Wa who wrote (6)3/31/1999 9:12:00 PM
From: Shoot1st  Read Replies (2) | Respond to of 27
 
BICO may well have been the original hype-a-rama. Eight years ago, give or take a couple of years, it ran from .125 to about $8 in a flash.

The object was to market a non-invasive glucose monitor for diabetics. Press release after Press release eluding to FDA ok any day went on for years.

Pittsburgh Post Gazette has run many articles chastising mgt for sucking the company dry and issuing multi-millions of shares to feed themselves.

When they stopped the mirage in USA....they tried Europe.

You can get info on line from the Post Gazette. It is an adventure for every rookie trader to take. It is also one of the sadist examples of using the promise of new medical technology to generate continued stock sale income.

Shoot



To: Ben Wa who wrote (6)3/31/1999 10:06:00 PM
From: Sir Auric Goldfinger  Read Replies (1) | Respond to of 27
 
Copytele: self enrichment through option sales. No verifable product.